SILO PHARMA, INC. Accounts Payable
SILO PHARMA, INC. (SILO) had Accounts Payable of $35.00 thousand as of 2025-12-31, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:AccountsPayableCurrentAndNoncurrent · last filed 2026-08-13
- 2025-12-31: Accounts Payable $35.00K.
- 2025-06-30: Accounts Payable $135.00K.
- 2025-03-31: Accounts Payable $97.40K.
- 2024-12-31: Accounts Payable $147.40K.
| Period end | Accounts Payable |
|---|---|
| 2025-12-31 | $35.00K 10-Q · filed 2026-08-13 |
| 2025-06-30 | $135.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $97.40K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $147.40K 10-Q · filed 2026-08-13 |
| 2020-12-18 | $6.50K 10-K/A · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |